TNF and rheumatoid arthritis: Recently, anti-TNF antibody fragments linked to antihuman albumin were designed to prolong and stabilize blood concentrations of the antibody, with a phase II/III clinical trial demonstrating that the fragments were efficacious when administered every 4 weeks to active RA patients [44].